Jubilant Ingrevia Hits 52-Week High, Outperforms Sector with Strong Performance.

Jubilant Ingrevia, a midcap pharmaceutical and drugs company, has recently hit a 52-week high on October 3rd, 2024. The stock has been performing well in the market, with a 'Hold' call from MarketsMOJO.

On October 3rd, the stock reached a new high of Rs. 818.25, outperforming the sector by 5.2%. It has also been gaining for the past three days, with a 9.82% increase in returns during this period. However, the stock opened with a loss of -2.66% today, showing some volatility in its performance.

The intraday high for the stock was Rs. 818.25, while the intraday low was Rs. 751.05. This indicates a high volatility of 6.14% for the stock, calculated from the weighted average price.

Jubilant Ingrevia is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.

In the past year, Jubilant Ingrevia has shown a strong performance with a 70.03% increase, compared to the Sensex's performance of 27.41%. This showcases the company's growth and potential in the pharmaceutical and drugs industry.

Overall, Jubilant Ingrevia's recent 52-week high and consistent performance in the market make it a promising midcap company to watch out for.